AKBA vs ECL
Akebia Ther (AKBA) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported AKBA revenue for 2024-12-31 was $160.2M. Net income was -$69.4M. Revenue was down 17.7% from 2023-12-31 to 2024-12-31. AKBA currently screens at market cap $260.1M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
AKBA currently screens at market cap $260.1M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the AKBA and ECL stock pages for the full models.
Not investment advice.